
The Precision Oncology Revolution: From Bench to Bedside
This keynote explores the transformative journey of precision oncology, from early genomic research to current clinical applications, covering personalised treatment approaches and their impact on patient outcomes worldwide.
Prof. David Williams , Harvard Medical School, USA

Liquid Biopsy in Early Cancer Detection: A New Paradigm
This presentation covers emerging liquid biopsy technologies and their application in early cancer detection, monitoring treatment response, and identifying resistance mechanisms in real-time.
Dr. Sarah Chen , National Cancer Centre, Singapore

Genomic Profiling in Solid Tumours: 2026 Clinical Update
An in-depth review of the latest genomic profiling techniques and their clinical utility in guiding treatment decisions for patients with solid tumours across multiple cancer types.
Prof. James Harper , Mayo Clinic, USA
Precision Medicine in Practice: Real-World Implementation Challenges
A moderated discussion on the practical challenges of implementing precision oncology in diverse clinical settings, from well-resourced academic centres to community practices.
Moderated Panel — Multiple Speakers

CAR-T Cell Therapy: Clinical Milestones and Future Directions
Examining the remarkable journey of CAR-T cell therapy from experimental to standard-of-care, with a focus on next-generation strategies to extend its reach beyond haematological malignancies.
Prof. Hiroshi Tanaka , University of Tokyo, Japan

Artificial Intelligence & Machine Learning in Oncology Imaging
Exploring cutting-edge AI applications in radiology and pathology for cancer diagnosis, staging, and treatment response assessment, with case studies from leading medical centres.
Dr. John Kim , Samsung Medical Centre, South Korea

Targeted Therapy Resistance Mechanisms in Melanoma
A comprehensive review of resistance mechanisms to BRAF/MEK inhibitors in melanoma, with discussion of novel combination strategies to overcome resistance and improve outcomes.
Prof. Elena Russo , European Institute of Oncology, Italy
Workshop: Nanomedicine & Targeted Drug Delivery
Hands-on workshop exploring nanoparticle-based drug delivery systems, from design principles to clinical translation. Limited to 50 participants.
Dr. Li Wei , Peking Union Hospital, China

Affordable Precision Diagnostics for South Asia
Presenting innovative approaches to making precision oncology diagnostics accessible and affordable in resource-limited settings across South Asia.
Dr. Meera Patel , Tata Memorial Hospital, India
Future of Global Cancer Care: Equity, Access & Innovation
A moderated discussion bringing together international experts to debate strategies for improving cancer care access globally, reducing disparities, and translating research into practice.
Moderated Panel — Multiple Speakers

Cancer Care Equity in Low- and Middle-Income Countries
Addressing the persistent global inequalities in cancer care access, treatment outcomes, and research participation, with practical frameworks for building capacity in resource-limited settings.
Dr. Carlos Mendez , INCA, Brazil

Palliative Care Integration in Oncology: A Global Perspective
Exploring models for integrating palliative care into oncology practice across diverse healthcare systems, with emphasis on patient-centred approaches and cultural sensitivity.
Dr. Fatima Khalid , King Saud University, Saudi Arabia
Workshop: Survivorship Care Planning
Practical workshop on developing comprehensive survivorship care plans, addressing late effects, psychological well-being, and long-term surveillance strategies.
Multiple Facilitators
Farewell Lunch
13:00 – 14:30 · Main Dining Hall
Best Abstract Awards Ceremony
15:00 – 15:45 · Main Auditorium — Oral & Poster Categories
Closing Ceremony & Farewell
15:45 – 16:30 · Main Auditorium — Prof. David Williams